Monash antibiotic discovery to be developed in China

A new polymyxin antibiotic targeting Gram-negative ‘superbug’ infections, developed by scientists at the Monash Institute of Pharmaceutical Sciences and the Monash Biomedicine Discovery Institute

/Public Release. View in full here.